Reglagene is developing a first-in class, potent, orally available, blood-brain-barrier penetrant compound for high-grade glioma
Location: United States, Arizona, Tucson
Employees: 11-50
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | UACI | uaci.com |
| - | Angel Star... | angelstarv... |
Mentions in press and media 4
| Date | Title | Description |
| 04.03.2024 | Reglagene Expands to Houston and Joins TMC's Accelerator for Cancer Therapeutics | Reglagene's RGN6024 is on track to give new hope to provide orally administered therapy for brain cancer patients whose survival has historically been very low. Will speed development of RGN6024 therapy into the clinic This is a exciting. A... |
| 04.01.2024 | REGLAGENE RECEIVES FDA ORPHAN DRUG DESIGNATION FOR INNOVATIVE BRAIN CANCER TREATMENT | New therapy crosses blood-brain barrier to give new hope to patients with rare, aggressive cancer The obstacle has been crossing the blood-brain barrier, a natural filter preventing toxins and medicines from entering the brain. Only 2% of m... |
| 14.04.2022 | Pismo Ventures' National Life Science Startup Symposium Announces Top Applicants | “This Symposium contained a seriously high-value cohort of Life Science Startups. This relatively rapid-fire format was fun to witness and judge. Thank you for inviting me and Desert Angels to participate,” said Jeffrey Lang, Chairman, Dese... |
| - | Reglagene | “Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.” |